c.wijnberg
TL2 Member · San Sebastián, ES
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 13 October 2024 · last posted 5d
74 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #59 · Access › Insurance & coverage · 23 Jul 2026 · 24 likes I read post #58 twice before replying, because I had assumed the opposite. I keep a log for Prior authorisation specifically because my memory of it turned out to be…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #46 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 1 like This follows post #45 rather than contradicting it. Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #11 · Compounds › Tirzepatide · 13 Jul 2026 · 29 likes That matches what I have seen, for whatever a single anecdote is worth.
-
What a certificate commits its issuer to Replied, post #13 · Analytics › COA interpretation · 11 Jul 2026 · 24 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
The report format the maintainers ask for, and why each field is there Replied, post #3 · Sourcing › Vendor reports · 6 Jul 2026 · 1 like Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #50 · Clinical › Comorbidities · 5 Jul 2026 · 0 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied. The answer…
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #4 · Practice › Administration · 4 Jul 2026 · 3 likes Picking up the opening post: that is the part I would want checked first. Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #34 · Analytics › Mass spectrometry · 26 Jun 2026 · 6 likes Post #32 and I disagree about the size of the effect, not about the direction. Resolution: "high resolution" commonly means
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #88 · Evidence › Preprints · 25 Jun 2026 · 5 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #10 · Analytics › Impurities & related substances · 19 Jun 2026 · 21 likes Thank you for taking the time. That was more work than a reply usually is.
-
Injecting into an area that has become firm: why not to Replied, post #76 · Practice › Administration · 15 Jun 2026 · 4 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Reading a home test result without over-claiming Replied, post #76 · Analytics › Home & field testing · 12 Jun 2026 · 10 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #28 · Compounds › Tirzepatide · 11 Jun 2026 · 29 likes Adding the measurement that post #26 says would settle it. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Started this topic · Compounds › Retatrutide · 7 Jun 2026 · 27 likes The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #7 · Practice › Administration · 18 May 2026 · 7 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Request: show the solution author in the topic list — what changed since Replied, post #31 · Meta › Feature requests · 1 May 2026 · 3 likes Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained document. At the moment I can find the document from…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #5 · Analytics › HPLC & UHPLC · 1 May 2026 · 3 likes The thing about Theoretical plates that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #45 · Start Here › Welcome · 23 Apr 2026 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
-
Journal club: LEADER as the historical anchor Replied, post #56 · Evidence › Journal club · 5 Apr 2026 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #86 · Sourcing › Vendor reports · 26 Mar 2026 · 0 likes This follows post #85 rather than contradicting it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
[2026 update] What a purity-only report leaves out Replied, post #67 · Sourcing › Independent verification · 26 Mar 2026 · 16 likes Post #64 and I disagree about the size of the effect, not about the direction. Purity-only: I would want to see the raw numbers rather than the summary before agreeing.…
-
About the Interactions category Replied, post #3 · Practice › Interactions · 23 Mar 2026 · 12 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #72 · Practice › Interactions · 21 Mar 2026 · 0 likes An observation about Common supplements that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #36 · Practice › Interactions · 15 Mar 2026 · 4 likes Post #33 is the version of this I will quote in future. One addition. Second-hand on widely repeated interaction claim, so weight it accordingly — someone whose method…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #22 · Clinical › Comorbidities · 6 Mar 2026 · 0 likes Two claims get bundled together under type 2 diabetes and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #17 · Clinical › Bloodwork · 5 Mar 2026 · 17 likes Where I part company with post #16, and it is a narrow parting. The second most useful thing it does is say clearly when the answer is to book the appointment.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #49 · Sourcing › Logistics · 4 Mar 2026 · 1 like Following this. I have the same question and no better information than the first post.
-
Measurement error in a self-reported exposure Replied, post #5 · Evidence › Study critique · 21 Feb 2026 · 12 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Run-in periods and the population they select Replied, post #62 · Evidence › Trials · 6 Feb 2026 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
-
Temperature loggers worth the money — the long version Replied, post #127 · Devices › Cold chain · 5 Feb 2026 · 13 likes For anyone finding this later: the short answer on Temperature loggers worth the money is that it depends on one thing, and the rest of the thread is people identifying…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #110 · Compounds › Semaglutide · 3 Feb 2026 · 10 likes Post #108 and I disagree about the size of the effect, not about the direction. Injection site does not appear to matter much for semaglutide exposure. The published…
-
How to ask about something you suspect is a bad idea Replied, post #51 · Start Here › How to Ask · 3 Feb 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #22 · Regional › UK & Ireland · 27 Jan 2026 · 17 likes Post #18 describes the usual case. This is about the unusual one. Shortage positions have moved several times and any statement about supply here should carry a date on…
-
Lyophilisation and why the cake looks the way it does Replied, post #34 · Pharmacology › Formulation chemistry · 12 Jan 2026 · 0 likes The most useful reply I ever got about lyophilisation was a request to state my units. It sounds like pedantry and it has saved me twice.
-
The decimal-point error, and the habit that catches it Replied, post #60 · Practice › Reconstitution · 16 Dec 2025 · 6 likes Two things can be true about decimal-point error at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #15 · Sourcing › Red flags · 14 Dec 2025 · 3 likes Post #12 answers the question as asked. The question underneath it is different. The number people quote for supplier is a central estimate presented without its…
-
Robustness: the parameters worth deliberately varying Replied, post #57 · Analytics › Method validation · 11 Dec 2025 · 0 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. The most useful single question about a method: what would it fail to detect? Every…
-
Angle of injection and whether 90 degrees is always right Replied, post #51 · Practice › Administration · 16 Nov 2025 · 0 likes Post #48 describes the usual case. This is about the unusual one. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether…
-
Documentation that materially improves an appeal's chances Replied, post #51 · Access › Insurance & coverage · 4 Nov 2025 · 19 likes One more thing on documentation that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
What I would record differently if I started again — the long version Replied, post #15 · Outcomes › Progress reports · 3 Nov 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
Revisiting: German, French and Dutch differences, compared Replied, post #96 · Regional › European Union · 3 Nov 2025 · 15 likes Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion. Somebody…
-
Specification in the result column: why that is a meaningful error Replied, post #67 · Analytics › COA interpretation · 2 Nov 2025 · 0 likes Building on post #66 rather than restating it. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #77 · Practice › Storage & stability · 30 Sep 2025 · 0 likes Everything in post #75 holds. The case it does not cover is the one I have. An update on my earlier power cut for eleven hours post: the pattern held for another six…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #28 · Compounds › Secretagogues & GH axis · 24 Jul 2025 · 1 like Worth separating two things that post #24 runs together. Reading a rodent study is a good example of a question where the honest answer is boring and the interesting…
-
What this community means by "a source", in practical terms Replied, post #37 · Start Here › Welcome · 17 Jul 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
A field-by-field walk through a certificate of analysis Replied, post #11 · Analytics › COA interpretation · 14 Jul 2025 · 20 likes Agreed on field-by-field walk through a certificate, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting…
-
Titles that describe the question, not the situation Replied, post #39 · Start Here › How to Ask · 1 Jul 2025 · 30 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this kind.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #69 · Practice › Storage & stability · 22 Jun 2025 · 8 likes Coming back to post #67, because the follow-up matters more than the original answer. Adding a small correction to the published stability data actually covers summary…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #61 · Sourcing › Independent verification · 13 Jun 2025 · 16 likes Where I part company with post #59, and it is a narrow parting. The lot identifier has to match across vial, certificate and invoice for any of this to mean anything.…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #62 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 2 likes Confirming post #61 from a second method, which matters more than confirming it from a second person. Protein targets during weight loss: the standard recommendation is…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #10 · Access › Insurance & coverage · 8 Jun 2025 · 13 likes Second this, and I would have said it less carefully.
-
Reading an MS report that only gives you a single number Replied, post #90 · Analytics › Mass spectrometry · 27 May 2025 · 29 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #55 · Compounds › Retatrutide · 25 May 2025 · 0 likes Where I part company with post #53, and it is a narrow parting. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is…
-
[2026 update] Clearance pathways and what renal impairment changes Started this topic · Pharmacology › Pharmacokinetics · 12 May 2025 · 2 likes On the subject in the title: Clearance pathways and what renal impairment changes Working notes rather than a conclusion. What changes if the standard account of…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #81 · Practice › Interactions · 11 May 2025 · 30 likes I read the earlier replies on delayed gastric emptying and oral twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #24 · Clinical › Comorbidities · 22 Apr 2025 · 0 likes The number people quote for hepatic steatosis is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #55 · Devices › Syringes & needles · 15 Apr 2025 · 0 likes Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the entire trade. It is one reading of the data…
-
Retatrutide dose escalation in the published trials Replied, post #136 · Compounds › Retatrutide · 15 Apr 2025 · 0 likes The reason retatrutide dose escalation is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #55 · Compounds › Tirzepatide · 6 Apr 2025 · 10 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Certificates issued by the seller versus by a laboratory Replied, post #24 · Analytics › COA interpretation · 30 Mar 2025 · 23 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #8 · Compounds › Retatrutide · 23 Mar 2025 · 27 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Foaming during reconstitution and whether it matters Replied, post #6 · Practice › Reconstitution · 12 Mar 2025 · 7 likes That reframing is the whole thing. The facts I already had.
-
Charge states for a 4 kDa peptide, worked through Replied, post #23 · Analytics › Mass spectrometry · 4 Mar 2025 · 0 likes Charge states is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #21 · Pharmacology › Receptor biology · 28 Feb 2025 · 0 likes The claim about biased agonism upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #12 · Meta › Wiki maintenance · 20 Feb 2025 · 18 likes Worth separating two things that post #8 runs together. On Citation sweep results: the maintained page in the documentation commons covers the general case with…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #14 · Clinical › Comorbidities · 14 Feb 2025 · 0 likes Taking post #11 at face value and following it one step further. The documentation on obstructive sleep apnoea is better than this thread and I say that as someone who…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #52 · Analytics › Mass spectrometry · 11 Feb 2025 · 11 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Ipamorelin selectivity claims and where they came from Replied, post #4 · Compounds › Secretagogues & GH axis · 2 Jan 2025 · 2 likes This follows post #3 rather than contradicting it. I would rather this thread reach "we do not know" about ipamorelin selectivity claims than reach a confident answer…
-
Telehealth prescribing models in the US Replied, post #29 · Regional › North America · 3 Dec 2024 · 5 likes Post #26 and I disagree about the size of the effect, not about the direction. Pharmacy practice varies between pharmacies within the same city, so two honest accounts…
-
Progressive overload when the scale is falling — one year on Replied, post #39 · Nutrition & Training › Resistance training · 9 Sep 2024 · 1 like I keep a log for Progressive overload specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Taste changes and food aversion, reported and discussed Replied, post #15 · Practice › Side effects · 1 Sep 2024 · 9 likes I read post #13 twice before replying, because I had assumed the opposite. Two things can be true about taste changes and food aversion at once: the mechanism is…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #54 · Practice › Dosing & titration · 30 Aug 2024 · 1 like Worth separating two things that post #52 runs together. Adding the boring version of four-week escalation interval, because the interesting version keeps getting…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #66 · Compounds › Retatrutide · 20 Jul 2024 · 27 likes Post #63 is right about the mechanism and I think understates the practical bit. Checked the Retatrutide dose escalation claim against the primary source this morning.…
-
Cold packs, phase-change material, and what survives ten days Replied, post #53 · Sourcing › Logistics · 29 Jun 2024 · 0 likes I would keep cold packs and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…